Economic Times
The Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Several major pharmaceutical companies have already made pricing agreements or expanded U.S. operations to avoid these penalties. The plans are not finalized and may include exemptions for certain medicines.
Go to News Site